|
Volumn 9, Issue 6, 2014, Pages 1138-1140
|
Glomerular disease: Looking beyond pathology
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AUTOANTIBODY;
BIOLOGICAL MARKER;
GLOMERULUS BASEMENT MEMBRANE ANTIBODY;
NEUTROPHIL CYTOPLASMIC ANTIBODY;
PHOSPHOLIPASE A2 RECEPTOR ANTIBODY;
UNCLASSIFIED DRUG;
ARTICLE;
CELL MATURATION;
CLINICAL RESEARCH;
DISEASE CLASSIFICATION;
DISEASE COURSE;
DISEASE MODEL;
DRUG TARGETING;
ENDOTHELIUM;
ENVIRONMENTAL FACTOR;
GENETIC SUSCEPTIBILITY;
GLOMERULOPATHY;
GLOMERULUS BASEMENT MEMBRANE;
HUMAN;
IMMUNE RESPONSE;
KIDNEY FUNCTION;
METHODOLOGY;
NONHUMAN;
PERSONALIZED MEDICINE;
PODOCYTE;
CLASSIFICATION;
CYTOLOGY;
GLOMERULUS;
KIDNEY DISEASES;
MEDICAL RESEARCH;
METABOLISM;
VASCULAR ENDOTHELIUM;
VASCULARIZATION;
AUTOANTIBODIES;
BIOMEDICAL RESEARCH;
ENDOTHELIUM, VASCULAR;
HUMANS;
KIDNEY DISEASES;
KIDNEY GLOMERULUS;
PODOCYTES;
PRECISION MEDICINE;
|
EID: 84925124163
PISSN: 15559041
EISSN: 1555905X
Source Type: Journal
DOI: 10.2215/CJN.01450214 Document Type: Article |
Times cited : (13)
|
References (0)
|